TRETINOIN and RASH

Overview

RASH is the #7 most commonly reported adverse reaction for TRETINOIN, manufactured by Bausch Health US, LLC. There are 387 FDA adverse event reports linking TRETINOIN to RASH. This represents approximately 1.7% of all 22,211 adverse event reports for this drug.

Patients taking TRETINOIN who experience rash should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

RASH is a less commonly reported adverse event for TRETINOIN, but still significant enough to appear in the safety profile.

Other Side Effects of TRETINOIN

In addition to rash, the following adverse reactions have been reported for TRETINOIN:

• OFF LABEL USE — 897 reports
• DRUG INEFFECTIVE — 788 reports
• PAIN — 535 reports
• PRODUCT USE IN UNAPPROVED INDICATION — 463 reports
• VOMITING — 462 reports
• NAUSEA — 423 reports
• HEADACHE — 377 reports
• DIARRHOEA — 361 reports
• PARAESTHESIA — 356 reports
• FATIGUE — 336 reports

Other Drugs Associated with RASH

The following drugs have also been linked to rash in FDA adverse event reports:

Does TRETINOIN cause RASH?

RASH has been reported as an adverse event in 387 FDA reports for TRETINOIN. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is RASH with TRETINOIN?

RASH accounts for approximately 1.7% of all adverse event reports for TRETINOIN, making it a notable side effect.

What should I do if I experience RASH while taking TRETINOIN?

If you experience rash while taking TRETINOIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages